Board & Management Update

Allergy Therapeutics PLC – Board Change

Allergy Therapeutics plc (AIM: AGY), the fully integrated commercial biotechnology company specialising in allergy vaccines, announces that Mary Tavener will join the Board of Allergy Therapeutics as a Non-Executive Director...

Read More

Scancell Holdings Plc – Board Appointment

Scancell, the developer of novel immunotherapies for the treatment of cancer, announces that, further to the Company's announcement on 13 June 2019, Martin Diggle, Co-Founder and Portfolio Manager of Vulpes...

Read More